CorMedix Inc.
CRMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $883,066 | $836,869 | $401,905 | $498,219 |
| - Cash | $48,493 | $159,309 | $66,286 | $40,651 |
| + Debt | $148,921 | $435 | $477 | $517 |
| Enterprise Value | $983,494 | $677,996 | $336,096 | $458,085 |
| Revenue | $104,275 | $39,737 | $39,082 | $31,210 |
| % Growth | 162.4% | 1.7% | 25.2% | – |
| Gross Profit | $93,081 | $37,874 | $37,485 | $30,034 |
| % Margin | 89.3% | 95.3% | 95.9% | 96.2% |
| EBITDA | $57,315 | $20,519 | $20,816 | $13,608 |
| % Margin | 55% | 51.6% | 53.3% | 43.6% |
| Net Income | $108,563 | $19,828 | $20,644 | $13,464 |
| % Margin | 104.1% | 49.9% | 52.8% | 43.1% |
| EPS Diluted | 1.26 | 0.28 | 0.3 | 0.22 |
| % Growth | 350% | -6.7% | 36.4% | – |
| Operating Cash Flow | $30,857 | $29,992 | $19,737 | -$5,615 |
| Capital Expenditures | -$506 | -$24 | -$10 | -$10 |
| Free Cash Flow | $30,351 | $29,968 | $19,726 | -$5,624 |